Contact
searchSearch
HMP Global
News

Getinge Group and Subsidiary MAQUET Cardiovascular Sign Agreement to Acquire Atrium Medical

10/03/2011

Wayne, NJ– October 3, 2011 – Getinge Group and its subsidiary, MAQUET Cardiovascular, a provider of cardiovascular technologies, announced today that it has signed a definitive agreement to acquire Atrium Medical Corporation for $680 million. Atrium offers medical device technologies for interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery. Atrium will operate as an independent, self-contained business unit of MAQUET Cardiovascular and will be led by current Atrium president, Trevor Carlton.

The transaction is expected to close in the fourth quarter of 2011, subject to U.S. Federal Trade Commission (FTC) approval.


News

Drug-Coated Balloons
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
06/02/2026
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
Advanced NanoTherapies (ANT)'s...
06/02/2026
Cath Lab Digest
Awards
ACC President Roxana Mehran, MD, FACC, Receives Andreas Grüntzig Ethica Award
05/28/2026
The award, named after Andreas Grüntzig, the pioneering German cardiologist who developed the first balloon angioplasty, is the highest honor presented by the Percutaneous Cardiovascular Registry (PCR).
The award, named after Andreas Grüntzig, the pioneering German cardiologist who developed the first balloon angioplasty, is the highest honor presented by the Percutaneous Cardiovascular Registry (PCR).
The award, named after Andreas...
05/28/2026
Cath Lab Digest
Cancer and Heart Disease
CARDIOCARE Project Celebrates Major Advances in Protecting Heart Health of Older Patients With Breast Cancer at Risk of Cardiotoxicity From Cancer Treatment
05/28/2026
Key takeaways: Project combines a wide range of data from more than 2,200 breast cancer patients to help the development of personalised AI-driven tools. Researchers have developed two dedicated applications to monitor both physical...
Key takeaways: Project combines a wide range of data from more than 2,200 breast cancer patients to help the development of personalised AI-driven tools. Researchers have developed two dedicated applications to monitor both physical...
Key takeaways: Project...
05/28/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Rolls Out New Radiation Protection System Nova-X® Across EMEA Following Very Promising Clinical Results
05/28/2026
Cathpax has signed several distribution contracts in different geographic regions and is supplying Nova-X® to various neurointerventional centers.
Cathpax has signed several distribution contracts in different geographic regions and is supplying Nova-X® to various neurointerventional centers.
Cathpax has signed several...
05/28/2026
Cath Lab Digest
CTO Viability
Rentrop Collateral Grade as an Angiographic Predictor of Myocardial Viability in Chronic Total Occlusion
05/28/2026
Your heart already has its own built-in bypass system that predicts whether the heart muscle is alive or dead, according to new research from the University of East Anglia and Norfolk and Norwich University Hospital. A new study reveals...
Your heart already has its own built-in bypass system that predicts whether the heart muscle is alive or dead, according to new research from the University of East Anglia and Norfolk and Norwich University Hospital. A new study reveals...
Your heart already has its own...
05/28/2026
Cath Lab Digest
Vertex Catheter (Jupiter Endovascular)
Pulmonary Embolism
Jupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial at EuroPCR 2026
05/26/2026
The Vertex system leverages the company’s patented Transforming Fixation (TFX) platform technology in a novel catheter system designed to navigate flexibly through the right heart and then stabilize on-demand in the pulmonary arteries for...
The Vertex system leverages the company’s patented Transforming Fixation (TFX) platform technology in a novel catheter system designed to navigate flexibly through the right heart and then stabilize on-demand in the pulmonary arteries for...
The Vertex system leverages the...
05/26/2026
Cath Lab Digest
Uncontrolled Hypertension
AstraZeneca's Baxfendy Approved in U.S. as Aldosterone Synthase Inhibitor Treatment for Adults With Hypertension
05/26/2026
AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood...
AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood...
...
05/26/2026
Cath Lab Digest
Gene-Editing Approaches
Single Dose of Lilly's PCSK9 Base Editor, VERVE-102, Reduced PCSK9 by up to 88% and LDL-C by up to 62%, With Durable Effects Supporting Potential as One-Time Hypercholesterolemia Treatment
05/26/2026
Eli Lilly and Company announced positive Phase 1b Heart-2 study results for VERVE-102, an investigational in vivo base editing medicine designed to durably turn off the PCSK9 gene in the liver and lower blood low-density lipoprotein...
Eli Lilly and Company announced positive Phase 1b Heart-2 study results for VERVE-102, an investigational in vivo base editing medicine designed to durably turn off the PCSK9 gene in the liver and lower blood low-density lipoprotein...
Eli Lilly and Company announced...
05/26/2026
Cath Lab Digest
Inflammation
Cardiometabolic Clinical Data Support Potential of NodThera's Ruvonoflast to Treat Inflammation at the Source
05/26/2026
Boston, MA –  NodThera, a clinical-stage NLRP3 company developing a portfolio of potentially best-in-class brain-penetrant oral NLRP3 inhibitors to address inflammatory drivers of cardiometabolic and neurologic diseases, announced the...
Boston, MA –  NodThera, a clinical-stage NLRP3 company developing a portfolio of potentially best-in-class brain-penetrant oral NLRP3 inhibitors to address inflammatory drivers of cardiometabolic and neurologic diseases, announced the...
Boston, MA –  NodThera, a...
05/26/2026
Cath Lab Digest
Intravascular Lithotripsy
AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study
05/21/2026
BOSTON--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, announced the enrollment of the first patient in its first-in-human (FIH) study for...
BOSTON--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, announced the enrollment of the first patient in its first-in-human (FIH) study for...
BOSTON--Amplitude Vascular...
05/21/2026
Cath Lab Digest

Latest

Clinical Images
Severe Coronary Vasospasm Mimicking STEMI After Drug-Coated Balloon Angioplasty
06/01/2026
Kit Yee Chu, DO, PhD; Zain Abidi, DO; Ghassan Dalloul, MD, FACC
A 54-year-old man with coronary artery disease with multiple prior percutaneous coronary interventions, hypertension, paroxysmal atrial fibrillation on apixaban, hyperlipidemia, prior cerebrovascular accident with residual right-sided...
A 54-year-old man with coronary artery disease with multiple prior percutaneous coronary interventions, hypertension, paroxysmal atrial fibrillation on apixaban, hyperlipidemia, prior cerebrovascular accident with residual right-sided...
A 54-year-old man with coronary...
06/01/2026
Journal of Invasive Cardiology
Clinical Images
When Spasm Mimics STEMI: A Post-PCI Surprise
05/28/2026
Keshav Sachdeva, MD, DM; Vandeep Basra, MD, DM; Suraj Kumar, MD, DM; Bhupinder Singh, MD, DM; Tejinder Singh Malhi, MD, DM
A 54-year-old man with a history of alcohol use, smoking, and hypertension presented with unstable angina. Baseline electrocardiogram and transthoracic echocardiography were unremarkable.
A 54-year-old man with a history of alcohol use, smoking, and hypertension presented with unstable angina. Baseline electrocardiogram and transthoracic echocardiography were unremarkable.
A 54-year-old man with a history...
05/28/2026
Journal of Invasive Cardiology
Clinical Images
When the Left Ventricle Dances: Ballerina Foot Appearance in Hypertrophic Cardiomyopathy
05/27/2026
Mohit Gupta, MD; Anwar Hussan Ansari, MD, DM; Puneet Gupta, MD, DM; Anunay Gupta, MD, DM; Devesh Kumar, MD, MRCP, DM
A 30-year-old man presented with acute onset chest pain followed by an episode of syncope. He had no prior history of hypertension, diabetes, or any other known cardiac disease.
A 30-year-old man presented with acute onset chest pain followed by an episode of syncope. He had no prior history of hypertension, diabetes, or any other known cardiac disease.
A 30-year-old man presented with...
05/27/2026
Journal of Invasive Cardiology
Original Contribution
Impact of Ultra-High-Pressure OPN NC Balloons in Complex Coronary Interventions: Indications, Safety, and Efficacy
05/27/2026
Miguel Ángel Montilla-Garrido, MD; Santiago Jesús Camacho-Freire, MD, PhD, Prof; Elena Izaga-Torralba, MD, PhD; Carmen Lluch-Requerey, MD; Jessica Roa-Garrido, MD; Oscar Lagos-De Grande, MD; Antonio Enrique Gómez-Menchero, MD
The study evaluated the indication for the use, safety, and efficacy of the OPN NC balloon (SIS Medical AG) in real-world settings.
The study evaluated the indication for the use, safety, and efficacy of the OPN NC balloon (SIS Medical AG) in real-world settings.
The study evaluated the...
05/27/2026
Journal of Invasive Cardiology
Clinical Images
Endovascular Repair of Recurrent Coarctation With Pseudoaneurysm After Prior Bare-Metal Stent Using Thoracic Branched Endoprosthesis
05/22/2026
Pradyumna Agasthi, MD; Kaitlyn Krebushevski, MD; Allison K. Cabalka, MD; Jason H. Anderson, MD
The authors report use of a thoracic branch endoprostheses to treat recurrent coarctation of the aorta in a patient presenting with an aortic pseudoaneurysm and a peak-to-peak gradient of 29 mm Hg between the ascending and descending aorta.
The authors report use of a thoracic branch endoprostheses to treat recurrent coarctation of the aorta in a patient presenting with an aortic pseudoaneurysm and a peak-to-peak gradient of 29 mm Hg between the ascending and descending aorta.
The authors report use of a...
05/22/2026
Journal of Invasive Cardiology
Clinical Images
Endovascular Management for Symptomatic Superior Vena Cava Syndrome in a Patient on Hemodialysis
05/21/2026
Keshav Sachdeva, MD, DM; Hardik Jain, MD, DM; Suraj Kumar, MD, DM; Tejinder Singh Malhi, MD, DM; Saurabh Nayak, MD, DM; Bhupinder Singh, MD, DM
A 59-year-old woman with end-stage renal disease undergoing maintenance hemodialysis through sequential right and left internal jugular venous catheters presented with progressive facial and neck swelling, dyspnea, and a non-functioning,...
A 59-year-old woman with end-stage renal disease undergoing maintenance hemodialysis through sequential right and left internal jugular venous catheters presented with progressive facial and neck swelling, dyspnea, and a non-functioning,...
A 59-year-old woman with...
05/21/2026
Journal of Invasive Cardiology
Original Contribution
Differential Effect of Chronic Kidney Disease on Right-Sided Extravalvular Damage in Low-Flow, Low-Gradient Aortic Stenosis
05/14/2026
Eric J. Kim, MD, MBE; Yash Prakash, MD; Hassan Beesley, MD; Grigory Manyak, MD; Mihir Prakash; Lakshay Chopra, MD; Akarsh Sharma, MD; Carlo Mannina, MD; George D. Dangas, MD, PhD; Lucy M. Safi, DO; Sahil Khera, MD, MPH; Samin K. Sharma, MD; Annapoorna S. Kini, MD; Gilbert H.L. Tang, MD, MSc, MBA; Stamatios Lerakis, MD, PhD
The study examined the association between chronic kidney disease (CKD) and right-sided extravalvular damage within low-flow, low-gradient aortic stenosis and across each stage of CKD.
The study examined the association between chronic kidney disease (CKD) and right-sided extravalvular damage within low-flow, low-gradient aortic stenosis and across each stage of CKD.
The study examined the...
05/14/2026
Journal of Invasive Cardiology
SCAI CAIC logo
SCAI 2026
Left Atrial Appendage Occlusion Outside the Box: New Frontiers in Patient Selection
05/08/2026
Laura Simson, MA
In this 2026 SCAI session, Dr Saibal Kar explored how LAAO is moving beyond its traditional use in patients with nonvalvular AFib who are ineligible for anticoagulation.
In this 2026 SCAI session, Dr Saibal Kar explored how LAAO is moving beyond its traditional use in patients with nonvalvular AFib who are ineligible for anticoagulation.
In this 2026 SCAI session, Dr...
05/08/2026
Journal of Invasive Cardiology
Wearable AF Screening
Smartwatch Screening Detects More Atrial Fibrillation in High-Risk US Adults
05/08/2026
Laura Simson, MA
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial...
05/08/2026
Journal of Invasive Cardiology
Original Contribution
Real-World Analysis of Outcomes of Patients Undergoing Coronary Intravascular Lithotripsy Versus Atherectomy for Calcified Coronary Artery Disease: Findings From the TriNetX Database
05/04/2026
Vikash Jaiswal, MD; Muhammad Hanif, MD; Yusra Mashkoor, MBBS; Aymen Ahmed, MBBS; Gregory Mishkel, MD; Jonathan Rosenberg, MD; Mark J. Ricciardi, MD; Arman Qamar, MD, MPH
This real-world study compared outcomes of coronary intravascular lithotripsy vs atherectomy using the TriNetX Global Collaborative Network.
This real-world study compared outcomes of coronary intravascular lithotripsy vs atherectomy using the TriNetX Global Collaborative Network.
This real-world study compared...
05/04/2026
Journal of Invasive Cardiology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use